Search
for
Sort by
Research 25
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Subject Index
- Drugs that affect autonomic functions or the extrapyramidal system
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- Hair growth-promoting activity of components derived from sweet potato shochu
- Novel drugs of United States Food and Drug Administration approved in 2024
- New treatment modalities of alopecia areata
- Técnica actual del trasplante de pelo de unidades foliculares
- Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study
- Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Improved anaphylaxis referral rates to specialized services from an Emergency Department
- Methotrexate injection site reactions: Case report and literature review
- Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma
- Biologics in the management of childhood atopic dermatitis
- Scalp Microbiome and Sebum Composition in Japanese Male Individuals with and without Androgenetic Alopecia
- Effect of Dietary Methylsulfonylmethane Supplementation on Growth Performance, Hair Quality, Fecal Microbiota, and Metabolome in Ragdoll Kittens
- Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota–Intestinal Barrier Axis in Aged Mice
- Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota–Intestinal Barrier Axis in Aged Mice
- Sdr16c5 and Sdr16c6 control a dormant pathway at a bifurcation point between meibogenesis and sebogenesis